Hastings Paul J
Chief Executive Officer | Director
2 companies
Insider Signal Score
77
ExcellentTrades Analyzed
18
12M Win Rate
81.3%
Avg 3M Return
+21.0%
Avg 12M Return
+37.5%
Hastings Paul J is a Chief Executive Officer at Nkarta, Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 15 sells.
Estimated insider holdings value: $1.4M based on current market prices.
Holdings by Company
Transaction History
Showing 10 filings (page 2)
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 29, 2022 | NKTX Nkarta, Inc. | Chief Executive Officer | Sell | 23,874 | $13.03 | $311,088.99 | -4.5% | -58.4% | -89.0% | |
| Sep 21, 2022 | NKTX Nkarta, Inc. | Chief Executive Officer | Sell | 6,126 | $13.01 | $79,717.03 | -2.2% | -50.7% | -86.2% | |
| Jul 11, 2022 | PCRX Pacira Biosciences, Inc. | Director | Sell | 533 | $56.95 | $30,354.35 | -6.9% | -0.4% | -33.7% | |
| Sep 29, 2021 | NKTX Nkarta, Inc. | Chief Executive Officer | Sell | 8,500 | $27.18 | $231,050.59 | -1.9% | -44.1% | -52.6% | |
| Jun 21, 2021 | NKTX Nkarta, Inc. | Chief Executive Officer | Sell | 8,500 | $26.61 | $226,218.50 | -1.8% | +9.0% | -52.8% | |
| Jun 4, 2021 | PCRX Pacira Biosciences, Inc. | Director | Sell | 630 | $62.19 | $39,179.70 | -10.3% | -2.8% | +5.5% | |
| Mar 30, 2021 | NKTX Nkarta, Inc. | Chief Executive Officer | Sell | 17,000 | $30.74 | $522,540.49 | -2.3% | -13.4% | -63.5% | |
| Mar 5, 2021 | PCRX Pacira Biosciences, Inc. | Director | Sale+OE | 3,000 | $65.88 | $197,640.00 | -32.9% | - | - | |
| Jun 4, 2020 | PCRX Pacira Biosciences, Inc. | Director | Sell | 2,025 | $47.46 | $96,106.50 | -29.4% | - | - | |
| Jun 4, 2019 | PCRX Pacira Biosciences, Inc. | Director | Sell | 782 | $42.66 | $33,360.12 | -22.2% | - | - |